AdvisorShares Pure Cannabis ETFYOLO
YOLO
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
389% more call options, than puts
Call options by funds: $93K | Put options by funds: $19K
58% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 12
13% more capital invested
Capital invested by funds: $3.49M [Q2] → $3.95M (+$459K) [Q3]
1.81% more ownership
Funds ownership: 8.05% [Q2] → 9.86% (+1.81%) [Q3]
3% less funds holding
Funds holding: 60 [Q2] → 58 (-2) [Q3]
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Research analyst outlook
We haven’t received any recent analyst ratings for YOLO.
Financial journalist opinion
Negative
New York Post
1 month ago
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
Neutral
PRNewsWire
1 month ago
AdvisorShares Highlights the Pending Historic Reforms in US Cannabis Market
With cannabis approaching a pivotal juncture, AdvisorShares provides key investment exposure to multi-state operators through its industry-leading ETF suite BETHESDA, Md. , Oct. 21, 2024 /PRNewswire/ -- The U.S. cannabis market is approaching historic regulatory reforms, which AdvisorShares is monitoring closely as an investment leader in this specialized sector.
Positive
Proactive Investors
3 months ago
Cannabis stocks rally as Trump backs rescheduling, Florida legalization
Cannabis shares gained traction during Monday's session after Donald Trump endorsed the federal rescheduling of marijuana to allow research into its medical benefits. In a post on his social media platform Truth Social, the Republic presidential candidate said his administration would pass “common sense laws,” specifically the SAFER Banking Act and rescheduling cannabis to the lower-risk Schedule 3 of the Controlled Substances Act.
Negative
Proactive Investors
3 months ago
Cannabis stocks slide as DEA delays marijuana rescheduling until after the US election
Cannabis stocks moved lower on Tuesday as hopes that marijuana could be rescheduled as a lower-risk drug in the US before the upcoming election in November were dashed. Earlier this year, the Department of Justice (DOJ) in line with a recommendation from the Department of Health and Human Services proposed that because marijuana has accepted medical uses and less abuse potential than other substances in Schedules I and II of the Controlled Substances Act that the drug should be reclassified as Schedule III.
Positive
Proactive Investors
7 months ago
Cannabis stocks jump as Biden administration advances marijuana rescheduling proposal
US President Joe Biden confirmed on Thursday that the Justice Department is officially moving toward reclassifying cannabis as a lower-risk drug. The Justice Department's proposed rule will soon be posted which will be followed by a 60-day public comment period before the rule is potentially finalized, it was confirmed.
Neutral
ETF Trends
7 months ago
ETF Prime: Rosenbluth on Spot Ether, Marijuana ETFs, and More
On this week's episode of ETF Prime, host Nate Geraci is joined by VettaFi Head of Research Todd Rosenbluth to discuss hedge funds embracing ETFs, spot ether ETFs, and a potential shortage of ETF tickers, among other topics. Afterward, Bancreek CEO and CIO Andrew Skatoff spoke with Geraci about his investment philosophy.
Positive
ETF Trends
7 months ago
YTD Thematic Winners Reflect Change in Market Leadership
Looking at the ETFs with the highest returns YTD, a few thematic standouts have emerged. As a reminder regarding long-term investments, thematic investing is cyclical.
Positive
Fox Business
7 months ago
Investors wary of US cannabis ETFs despite recent rally
Marijuana ETFs and cannabis stocks shot higher last week after the U.S. Justice Department said it plans to reclassify marijuana as a less dangerous drug.
Positive
Seeking Alpha
7 months ago
Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling
The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.
Positive
The Street
7 months ago
Marijuana reclassified federally in major win for the legal cannabis industry
The U.S. government will reclassify marijuana as less risky as the recreational marijuana business continues to grow.
Charts implemented using Lightweight Charts™